Clinical Trials Browser

Phase 1 × Completed × tisagenlecleucel × Clear all

Lymphoma, Large B-Cell, Diffuse

NCT03630159 2022-08-15

PORTIA

Phase 1 Completed

12 enrolled

Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT02529813 2022-06-30

CD19-Specific T-cells in Treating Patients With Advanced Lymphoid Malignancies

Phase 1 Completed

26 enrolled

LymphoidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Biphenotypic, Acute, Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Clinical Trials

Relapsed/Refractory Large B-cell Lymphoma With NT-I7 Post-CD19 CAR T-cell Therapy

PORTIA

CD19-Specific T-cells in Treating Patients With Advanced Lymphoid Malignancies